SIGMATRON INTERNATIONAL INC - Quarter Report: 2020 October (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
Form 10-Q
__________________
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 2020
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 0-23248
SIGMATRON INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
_________________
Delaware |
36-3918470 |
(State or other jurisdiction of |
(I.R.S. Employer |
incorporation or organization) |
Identification No.) |
|
|
2201 Landmeier Road |
|
Elk Grove Village, Illinois |
60007 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (847) 956-8000
Title of each class Common Stock $0.01 par value per share |
Trading Symbol SGMA |
Name of each exchange on which registered The NASDAQ Capital Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
SigmaTron International, Inc.
October 31, 2020
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of a “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ☐ Accelerated Filer ☐
Non-accelerated Filer ☒ Smaller Reporting Company ☒
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of the registrant’s common stock, $0.01 par value, as of December 8, 2020: 4,257,508
2
SigmaTron International, Inc.
|
|||||
PART 1. |
FINANCIAL INFORMATION: |
Page No. |
|||
|
Item 1. |
||||
|
Condensed Consolidated Balance Sheets – October 31, 2020 (Unaudited) and April 30, 2020 |
4 | |||
|
Condensed Consolidated Statements of Operations – (Unaudited) |
||||
|
6 | ||||
|
Condensed Consolidated Statements of Changes in Stockholders’ |
||||
|
Equity – (Unaudited) Three and Six Months Ended October 31, 2020 and 2019 |
7 | |||
|
Condensed Consolidated Statements of Cash Flows – (Unaudited) |
||||
|
8 | ||||
|
Notes to Condensed Consolidated Financial Statements – (Unaudited) |
10 | |||
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and |
|||
|
25 | ||||
|
Item 3. |
33 | |||
|
Item 4. |
33 | |||
|
|||||
PART II |
OTHER INFORMATION: |
||||
|
Item 1. |
33 | |||
|
Item 1A. |
34 | |||
|
Item 2. |
34 | |||
|
Item 3. |
34 | |||
|
Item 4. |
34 | |||
|
Item 5. |
34 | |||
|
Item 6. |
35 | |||
|
36 | ||||
|
3
Condensed Consolidated Balance Sheets
|
|||||
|
October 31, |
||||
|
2020 |
April 30, |
|||
|
(Unaudited) |
2020 |
|||
|
|||||
Current assets: |
|||||
Cash and cash equivalents |
$ |
4,956,038 |
$ |
6,779,445 | |
|
|||||
Accounts receivable, less allowance for doubtful accounts of |
|||||
$395,969 and $727,252 at October 31, 2020 and April 30, 2020, |
24,633,138 | 30,804,976 | |||
Inventories, net |
83,940,180 | 87,179,369 | |||
Prepaid expenses and other assets |
1,044,386 | 1,510,943 | |||
Refundable and prepaid income taxes |
1,398,702 | 1,699,970 | |||
Other receivables |
5,340,198 | 2,642,094 | |||
|
|||||
Total current assets |
121,312,642 | 130,616,797 | |||
|
|||||
Property, machinery and equipment, net |
33,735,679 | 33,935,760 | |||
|
|||||
|
|||||
Intangible assets, net |
2,173,525 | 2,350,949 | |||
Deferred income taxes |
285,105 | 284,435 | |||
Other assets |
8,933,500 | 8,891,090 | |||
Total other long-term assets |
11,392,130 | 11,526,474 | |||
|
|||||
Total assets |
$ |
166,440,451 |
$ |
176,079,031 | |
|
|||||
Liabilities and stockholders' equity: |
|||||
Current liabilities: |
|||||
Trade accounts payable |
$ |
44,482,696 |
$ |
55,770,953 | |
Accrued wages |
6,383,294 | 4,206,825 | |||
Accrued expenses |
2,617,684 | 2,670,504 | |||
Income taxes payable |
449,883 | 469,143 | |||
Current portion of long-term debt |
5,380,120 | 2,878,160 | |||
Current portion of finance lease obligations |
1,650,763 | 1,902,295 | |||
Current portion of operating lease obligations |
2,078,990 | 2,150,161 | |||
|
|||||
Total current liabilities |
63,043,430 | 70,048,041 | |||
|
|||||
Long-term debt, less current portion |
36,882,880 | 38,537,064 | |||
Income taxes payable |
404,975 | 452,619 | |||
Finance lease obligations, less current portion |
1,124,309 | 1,884,722 | |||
Operating lease obligations, less current portion |
5,457,117 | 5,281,811 | |||
Other long-term liabilities |
869,460 | 810,769 | |||
Deferred income taxes |
41,060 | 188,206 | |||
|
|||||
Total long-term liabilities |
44,779,801 | 47,155,191 | |||
|
|||||
Total liabilities |
107,823,231 | 117,203,232 | |||
|
4
Commitments and contingencies |
|||||
|
|||||
Stockholders' equity: |
|||||
Preferred stock, $.01 par value; 500,000 shares |
|||||
authorized, none issued or outstanding |
- |
- |
|||
Common stock, $.01 par value; 12,000,000 shares |
|||||
authorized, 4,257,508 and 4,242,508 shares issued and |
|||||
outstanding at October 31, 2020 and April 30, 2020, respectively |
42,296 | 42,265 | |||
Capital in excess of par value |
23,634,711 | 23,619,513 | |||
Retained earnings |
34,940,213 | 35,214,021 | |||
|
|||||
Total stockholders' equity |
58,617,220 | 58,875,799 | |||
|
|||||
Total liabilities and stockholders' equity |
$ |
166,440,451 |
$ |
176,079,031 | |
|
|||||
The accompanying notes to the condensed consolidated financial statements are an integral part of these statements. |
5
SigmaTron International, Inc.
Condensed Consolidated Statements of Operations
|
|||||||||||
|
Three Months |
Three Months |
Six Months |
Six Months |
|||||||
|
Ended |
Ended |
Ended |
Ended |
|||||||
October 31, |
October 31, |
October 31, |
October 31, |
||||||||
|
2020 |
2019 |
2020 |
2019 |
|||||||
|
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) |
|||||||
|
|||||||||||
Net sales |
$ |
69,618,424 |
$ |
74,855,312 |
$ |
130,143,380 |
$ |
148,865,293 | |||
Cost of products sold |
62,858,882 | 67,725,826 | 119,111,647 | 134,775,475 | |||||||
|
|||||||||||
Gross profit |
6,759,542 | 7,129,486 | 11,031,733 | 14,089,818 | |||||||
|
|||||||||||
Selling and administrative expenses |
5,421,739 | 5,700,288 | 10,481,264 | 11,527,614 | |||||||
|
|||||||||||
Operating income |
1,337,803 | 1,429,198 | 550,469 | 2,562,204 | |||||||
|
|||||||||||
Other income |
(40,611) | (10,863) | (44,709) | (77,225) | |||||||
Interest expense |
308,613 | 462,772 | 646,877 | 1,054,000 | |||||||
Income (loss) before income tax expense |
1,069,801 | 977,289 | (51,699) | 1,585,429 | |||||||
|
|||||||||||
Income tax expense |
442,943 | 316,106 | 222,109 | 563,221 | |||||||
|
|||||||||||
Net income (loss) |
$ |
626,858 |
$ |
661,183 |
$ |
(273,808) |
$ |
1,022,208 | |||
|
|||||||||||
|
|||||||||||
Earnings (loss) per share – basic |
$ |
0.15 |
$ |
0.16 |
$ |
(0.06) |
$ |
0.24 | |||
|
|||||||||||
Earnings (loss) per share – diluted |
$ |
0.15 |
$ |
0.15 |
$ |
(0.06) |
$ |
0.24 | |||
|
|||||||||||
Weighted average shares of common stock outstanding |
|||||||||||
Basic |
4,257,508 | 4,242,508 | 4,254,247 | 4,242,196 | |||||||
|
|||||||||||
Weighted average shares of common stock outstanding |
|||||||||||
Diluted |
4,257,508 | 4,278,901 | 4,254,247 | 4,251,590 | |||||||
|
|||||||||||
The accompanying notes to the condensed consolidated financial statements are an integral part of these statements. |
6
SigmaTron International, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
|
For the six months ended October 31, 2020 (Unaudited) |
|||||||||||||
|
Capital in |
Total |
||||||||||||
|
Preferred |
Common |
excess of par |
Retained |
stockholders’ |
|||||||||
|
stock |
stock |
value |
earnings |
equity |
|||||||||
|
||||||||||||||
Balance at May 1, 2020 |
$ |
- |
$ |
42,265 |
$ |
23,619,513 |
$ |
35,214,021 |
$ |
58,875,799 | ||||
|
||||||||||||||
Restricted stock awards |
- |
31 | 15,198 |
- |
15,229 | |||||||||
|
||||||||||||||
Net loss |
- |
- |
- |
(900,666) | (900,666) | |||||||||
|
||||||||||||||
Balance at July 31, 2020 |
$ |
- |
$ |
42,296 |
$ |
23,634,711 |
$ |
34,313,355 |
$ |
57,990,362 | ||||
|
||||||||||||||
Net income |
- |
- |
- |
626,858 | 626,858 | |||||||||
|
||||||||||||||
Balance at October 31, 2020 |
$ |
- |
$ |
42,296 |
$ |
23,634,711 |
$ |
34,940,213 |
$ |
58,617,220 | ||||
|
|
For the six months ended October 31, 2019 (unaudited) |
|||||||||||||
|
Capital in |
Total |
||||||||||||
|
Preferred |
Common |
excess of par |
Retained |
stockholders’ |
|||||||||
|
stock |
stock |
value |
earnings |
equity |
|||||||||
|
||||||||||||||
Balance at May 1, 2019 |
$ |
- |
$ |
42,146 |
$ |
23,474,379 |
$ |
34,770,924 |
$ |
58,287,449 | ||||
|
||||||||||||||
Cumulative-effect adjustment for the adoption of Topic 842 |
- |
- |
- |
(5) | (5) | |||||||||
|
||||||||||||||
Net income |
- |
- |
- |
361,025 | 361,025 | |||||||||
|
||||||||||||||
Balance at July 31, 2019 |
$ |
- |
$ |
42,146 |
$ |
23,474,379 |
$ |
35,131,944 |
$ |
58,648,469 | ||||
|
||||||||||||||
|
||||||||||||||
Net income |
- |
- |
- |
661,183 | 661,183 | |||||||||
|
||||||||||||||
Balance at October 31, 2019 |
$ |
- |
$ |
42,146 |
$ |
23,474,379 |
$ |
35,793,127 |
$ |
59,309,652 | ||||
|
7
SigmaTron International, Inc.
Condensed Consolidated Statements of Cash Flows
|
|||||
|
Six |
Six |
|||
|
Months Ended |
Months Ended |
|||
|
October 31, |
October 31, |
|||
|
2020 |
2019 |
|||
|
(Unaudited) |
(Unaudited) |
|||
|
|||||
Cash flows from operating activities |
|||||
Net (loss) income |
$ |
(273,808) |
$ |
1,022,208 | |
|
|||||
Adjustments to reconcile net (loss) income |
|||||
to net cash provided by operating activities: |
|||||
Depreciation and amortization of property, machinery and equipment |
2,529,756 | 2,456,156 | |||
Amortization of right-of-use operating lease assets |
1,064,327 | 1,080,505 | |||
Restricted stock expense |
15,229 |
- |
|||
Deferred income tax expense |
(147,816) | 20,982 | |||
Amortization of intangible assets |
177,424 | 181,750 | |||
Amortization of financing fees |
76,248 | 55,498 | |||
Loss from disposal or sale of machinery and equipment |
141,245 | 17,598 | |||
Changes in operating assets and liabilities |
|||||
Accounts receivable |
6,171,838 | 1,516,504 | |||
Inventories |
3,239,189 | 14,164,330 | |||
Prepaid expenses and other assets |
(423,910) | (43,197) | |||
Refundable and prepaid income taxes |
301,268 | 220,427 | |||
Income taxes payable |
(66,904) | (17,485) | |||
Trade accounts payable |
(11,288,257) | (10,673,778) | |||
Operating lease liabilities |
104,135 | 459,112 | |||
Accrued expenses and wages |
1,911,747 | 932,247 | |||
|
|||||
Net cash provided by operating activities |
3,531,711 | 11,392,857 | |||
|
|||||
Cash flows from investing activities |
|||||
Purchases of machinery and equipment |
(2,470,920) | (588,334) | |||
Advances on other receivables |
(2,612,300) |
- |
|||
|
|||||
Net cash used in investing activities |
(5,083,220) | (588,334) | |||
|
|||||
Cash flows from financing activities |
|||||
Proceeds under equipment notes |
2,397,015 |
- |
|||
Payments of contingent consideration |
- |
(57,537) | |||
Payments under finance lease and sale leaseback agreements |
(1,011,945) | (1,162,402) | |||
Payments under equipment notes |
(283,684) | (205,850) | |||
Payments under building notes payable |
(160,983) | (140,000) | |||
Borrowings under revolving line of credit |
164,562,061 | 170,235,836 | |||
Payments under revolving line of credit |
(165,448,281) | (176,963,048) | |||
Payments of debt financing costs |
(326,081) | (46,866) | |||
|
|||||
Net cash used in financing activities |
(271,898) | (8,339,867) | |||
|
8
Change in cash and cash equivalents |
(1,823,407) | 2,464,656 | |||
Cash and cash equivalents at beginning of period |
6,779,445 | 1,005,810 | |||
|
|||||
Cash and cash equivalents at end of period |
$ |
4,956,038 |
$ |
3,470,466 | |
|
|||||
Supplementary disclosures of cash flow information |
|||||
Cash paid for interest |
$ |
624,959 |
$ |
1,053,706 | |
Cash paid for income taxes |
134,355 | 391,949 | |||
Purchase of machinery and equipment financed |
|||||
under finance leases |
- |
671,446 | |||
Financing of insurance policy |
302,074 | 54,000 | |||
|
9
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note A - Description of the Business
SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, the “Company”) operates in one business segment as an independent provider of electronic manufacturing services (“EMS”), which includes printed circuit board assemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the Company also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; and (6) assistance in obtaining product approval from governmental and other regulatory bodies.
Note B - Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of SigmaTron International, Inc. (“SigmaTron”), SigmaTron’s wholly-owned subsidiaries Standard Components de Mexico S.A., AbleMex, S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., Spitfire Controls (Cayman) Co. Ltd. and wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and SigmaTron Electronic Technology Co., Ltd. (“SigmaTron China”) and international procurement office SigmaTron Taiwan branch (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.
Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three and six month period ended October 31, 2020 is not necessarily indicative of the results that may be expected for the year ending April 30, 2021. The condensed consolidated balance sheet at April 30, 2020, was derived from audited annual financial statements but does not contain all of the footnotes disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2020.
COVID-19 and CARES Act
A pandemic of respiratory disease (abbreviated "COVID-19") began to spread globally, including to the United States, in early 2020. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 to be a public health emergency of international concern. The full impact of the COVID-19 outbreak is inherently uncertain at the time of this report. The COVID-19 outbreak has resulted in travel restrictions and in some cases, prohibitions of non-essential activities, disruption and shutdown of certain businesses and greater uncertainty in global financial markets. The full extent to which COVID-19 impacts the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak within the U.S., China, Mexico, Vietnam and Taiwan, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.
10
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note B - Basis of Presentation - Continued
Even after COVID-19 has subsided, the Company may continue to experience materially adverse impacts to its business as a result of its global economic impact, including any recession that has occurred or may occur in the future. There are no comparable recent events which may provide guidance as to the effect of the spread of COVID-19, and, as a result, the ultimate impact of COVID-19, or a similar health epidemic or pandemic, is highly uncertain and subject to change. The Company has adopted several measures in response to the COVID-19 outbreak. To date, the Company has been able to continue to meet the needs of its customers. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it will have a material adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2021.
On March 27, 2020, President Trump signed into law the “Coronavirus Aid, Relief, and Economic Security (CARES) Act.” The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations, increased limitations on qualified charitable contributions, and technical corrections to tax depreciation methods for qualified improvement property. It also appropriated funds for the U.S. Small Business Administration (“SBA”) Paycheck Protection Program (“PPP Loan”) loans that are forgivable in certain situations to promote continued employment, as well as Economic Injury Disaster Loans to provide liquidity to small businesses harmed by COVID-19.
As further described in Note E, the Company has applied for, and has received, funds under the PPP Loan in the amount of $6,282,973. The application for these funds required the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. This certification further required the Company to take into account its current business activity and its ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on its future adherence to the forgiveness criteria.
Due to the size of the PPP Loan, it is subject to review, which introduces a layer of uncertainty. If, despite the Company’s actions and certification that it satisfied all eligibility requirements for the PPP Loan, it is later determined that it violated applicable laws or was otherwise ineligible to receive the PPP Loan, the Company may be required to repay the PPP Loan in its entirety in a lump sum or be subject to additional penalties, which could also result in adverse publicity and damage to the Company’s reputation. If these events were to transpire, they could have a material adverse effect on the Company’s business, results of operations, financial condition and liquidity in fiscal year 2021 and beyond.
11
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note C - Inventories, net
The components of inventory consist of the following:
|
|||||
|
October 31, |
April 30, |
|||
|
2020 |
2020 |
|||
|
|||||
Finished products |
$ |
22,153,570 |
$ |
20,998,329 | |
Work-in-process |
4,483,188 | 5,215,280 | |||
Raw materials |
58,544,737 | 62,316,122 | |||
|
85,181,495 | 88,529,731 | |||
Less excess and obsolescence reserve |
(1,241,315) | (1,350,362) | |||
|
$ |
83,940,180 |
$ |
87,179,369 |
Note D - Earnings Per Share and Stockholders’ Equity
The following table sets forth the computation of basic and diluted earnings (loss) per share:
|
Three Months Ended |
Six Months Ended |
|||||||||
|
October 31, |
October 31, |
|||||||||
|
2020 |
2019 |
2020 |
2019 |
|||||||
|
|||||||||||
Net income (loss) |
$ |
626,858 |
$ |
661,183 |
$ |
(273,808) |
$ |
1,022,208 | |||
Weighted-average shares |
|||||||||||
Basic |
4,257,508 | 4,242,508 | 4,254,247 | 4,242,196 | |||||||
Effect of dilutive stock options |
- |
36,393 |
- |
9,394 | |||||||
|
|||||||||||
Diluted |
4,257,508 | 4,278,901 | 4,254,247 | 4,251,590 | |||||||
|
|||||||||||
Basic earnings (loss) per share |
$ |
0.15 |
$ |
0.16 |
$ |
(0.06) |
$ |
0.24 | |||
|
|||||||||||
Diluted earnings (loss) per share |
$ |
0.15 |
$ |
0.15 |
$ |
(0.06) |
$ |
0.24 |
Options to purchase 513,232 and 465,232 shares of common stock were outstanding at October 31, 2020 and 2019, respectively. There were no options granted during the six month periods ended October 31, 2020 and 2019. There was no stock option expense recognized for the three and six month periods ended October 31, 2020 and 2019. There was no balance of unrecognized compensation expense related to the Company’s stock option plans at October 31, 2020 and 2019. For the three month period ended October 31, 2020 and 2019, 314,740 and 147,706 shares, respectively, were not included in the diluted weighted average common shares outstanding calculation as they were anti-dilutive. For the six month periods ended October 31, 2020 and 2019, 306,420 and 241,465 shares, respectively, were not included in the diluted weighted average common shares outstanding calculation as they were anti-dilutive.
12
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note E - Long-term Debt
Debt and capital lease obligations consisted of the following at October 31, 2020 and April 30, 2020:
|
October 31, |
April 30, |
|||
|
2020 |
2020 |
|||
|
|||||
Debt: |
|||||
Notes Payable - Banks |
$ |
32,312,729 |
$ |
33,472,125 | |
Notes Payable - Buildings |
6,761,578 | 6,922,561 | |||
Notes Payable - Equipment |
3,413,609 | 1,300,278 | |||
Unamortized deferred financing costs |
(224,916) | (279,740) | |||
Total debt |
42,263,000 | 41,415,224 | |||
Less current maturities |
5,380,120 | 2,878,160 | |||
Long-term debt |
$ |
36,882,880 |
$ |
38,537,064 | |
|
|||||
Finance lease obligations |
$ |
2,775,072 |
$ |
3,787,017 | |
Less current maturities |
1,650,763 | 1,902,295 | |||
Total finance lease obligations, less current portion |
$ |
1,124,309 |
$ |
1,884,722 |
Notes Payable – Banks
On March 31, 2017, the Company entered into a $35,000,000 senior secured credit facility with U.S. Bank, which expires on March 31, 2022. The credit facility is collateralized by substantially all of the Company’s domestically located assets. The facility allows the Company to choose among interest rates at which it may borrow funds: the bank fixed rate of five percent or LIBOR plus one and one half percent (effectively 1.75% at October 31, 2020). Interest is due monthly.
On July 16, 2018, the Company and U.S. Bank entered into an amendment of the revolving line of credit under the senior secured credit facility. The amended revolving credit facility allows the Company to borrow up to the lesser of (i) $45,000,000 (the “Revolving Line Cap”) less reserves or (ii) the Borrowing Base, but no more than 90% of the Company’s Revolving Line Cap, except that the 90% limitation will expire if (i) the Company’s actual revolving loans for 90 consecutive days after the amendment’s effective date are less than 80% of the Company’s Borrowing Base and (ii) the Company maintains a Fixed Charge Coverage Ratio of 1.2 to 1.0 for four consecutive quarters. The amendment also imposes sublimits on categories of inventory of $10,500,000 on raw materials, $10,000,000 on finished goods and $28,000,000 on all eligible inventory.
On December 13, 2018, the Company and U.S. Bank entered into an amendment of the revolving credit facility. The amendment provides an exception to otherwise ineligible foreign receivables for up to $3,000,000 of receivables paid by certain enumerated account debtors outside of the U.S. and Canada.
13
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note E - Long-term Debt - Continued
On July 15, 2020 and August 7, 2020, the Company and U.S. Bank entered into amendments of the revolving credit facility. The amendments revised the Fixed Charge Coverage Ratio.
On September 8, 2020, the Company and U.S. Bank entered into an amendment of the revolving credit facility. The amendment allows the Company to borrow up to the lesser of (i) the Revolving Line Cap less reserves or (ii) the Borrowing Base, but no more than 80% of the Company’s Revolving Line Cap. The amendment also imposes sublimits on categories of other investments to $4,000,000.
As of October 31, 2020, there was $25,500,000 outstanding and $4,286,052 of unused availability under the U.S. Bank facility compared to an outstanding balance of $26,884,494 and $13,850,575 of unused availability at April 30, 2020. Deferred financing costs of $13,369 and $21,424 were capitalized during the three and six month periods ended October 31, 2020, respectively, which are amortized over the term of the agreement. As of October 31, 2020 and April 30, 2020, the unamortized amount offset against outstanding debt was $179,328 and $218,062, respectively.
On April 23, 2020, the Company received a PPP Loan from U.S. Bank, as lender, pursuant to the CARES Act, as administered by the SBA in the amount of $6,282,973. The PPP Loan, in the form of a promissory note, matures on April 23, 2022. No additional collateral or guarantees were provided by the Company for the PPP Loan. The PPP Loan provides for customary events of default. Under the CARES Act, loan forgiveness may be available for the sum of documented payroll costs, rent payments, mortgage interest and covered utilities during the 24-week period beginning on the date of loan disbursement. The amount of loan forgiveness will be reduced if recipients terminate employees or reduce salaries during the covered period. The Company may be required to repay any portion of the outstanding principal that is not forgiven, along with accrued interest, and it cannot provide any assurance that it will be eligible for loan forgiveness, or that any amount of the PPP Loan will ultimately be forgiven by the SBA. All aspects of the PPP Loan are subject to review by the SBA, including without limitation, the Company’s eligibility for and the size of the loan. The review procedures have not been made public. The Company cannot predict the outcome of that review nor be assured that all or any part of the PPP Loan will be forgiven. To the extent that all or part of the PPP Loan is not forgiven, the Company will be required to make payments, including interest accruing at an annual interest rate of 1.0%, beginning on the date of disbursement.
On March 15, 2019, the Company’s wholly-owned subsidiary, SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. Under the agreement SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $1,490,000 as of October 31, 2020, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 6.09%. The term of the facility extends to March 14, 2024. There was $498,275 outstanding under the facility at October 31, 2020 compared to an outstanding balance of $304,658 at April 30, 2020.
14
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note E - Long-term Debt - Continued
The Company is in compliance with its financial covenant as of October 31, 2020.
Notes Payable – Buildings
The Company entered into a mortgage agreement on December 21, 2017, in the amount of $5,200,000, with U.S. Bank to refinance the property that serves as the Company’s corporate headquarters and its Illinois manufacturing facility in Elk Grove Village, Illinois. The note requires the Company to pay monthly principal payments in the amount of $17,333, bears interest at a fixed rate of 4.0% per year and is payable over a fifty-one month period. Deferred financing costs of $74,066 were capitalized in fiscal year 2018 which are amortized over the term of the agreement. As of October 31, 2020, the unamortized amount included as a reduction to long-term debt was $24,214. A final payment of approximately $4,347,778 is due on or before March 31, 2022. The outstanding balance was $4,628,000 and $4,732,000 at October 31, 2020 and April 30, 2020, respectively.
The Company entered into a mortgage agreement on December 21, 2017, in the amount of $1,800,000, with U.S. Bank to refinance the property that serves as the Company’s engineering and design center in Elgin, Illinois. The note requires the Company to pay monthly principal payments in the amount of $6,000, bears interest at a fixed rate of 4.0% per year and is payable over a fifty-one month period. Deferred financing costs of $65,381 were capitalized in the fiscal year 2018 which are amortized over the term of the agreement. As of October 31, 2020 the unamortized amount included as a reduction to long-term debt was $21,374. A final payment of approximately $1,505,000 is due on or before March 31, 2022. The outstanding balance was $1,602,000 and $1,638,000 at October 31, 2020 and April 30, 2020, respectively.
The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank and Trust SSB to purchase the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103, bears interest at a fixed rate of 5.75% per year and is payable over a 120 month period. The outstanding balance was $531,578 and $552,561 at October 31, 2020 and April 30, 2020, respectively.
Notes Payable – Equipment
The Company routinely enters into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of these secured note agreements mature from November 2021 through May 2023, with quarterly installment payments ranging from $11,045 to $37,941 and a fixed interest rate ranging from 6.65% to 8.00%.
The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of these secured note agreements mature from March 2025 through October 2025, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate of 8.25%.
15
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note E - Long-term Debt - Continued
Annual maturities of the Company’s debt, net of deferred financing fees for the remaining periods as of October 31, 2020, are as follows:
|
Bank |
Building |
Equipment |
Total |
||||||||
|
||||||||||||
For the remaining 6 months of the fiscal year ending April 30: |
2021 |
$ |
4,168,854 |
$ |
161,593 |
$ |
438,870 |
$ |
4,769,317 | |||
For the fiscal years ending April 30: |
2022 |
27,420,684 | 6,135,090 | 877,428 | 34,433,202 | |||||||
|
2023 |
- |
47,752 | 652,117 | 699,869 | |||||||
|
2024 |
498,275 | 50,571 | 592,628 | 1,141,474 | |||||||
|
2025 |
- |
53,557 | 633,149 | 686,706 | |||||||
|
2026 |
- |
56,719 | 219,417 | 276,136 | |||||||
|
Thereafter |
- |
256,296 |
- |
256,296 | |||||||
|
$ |
32,087,813 |
$ |
6,761,578 |
$ |
3,413,609 |
$ |
42,263,000 | ||||
|
Finance Lease and Sales Leaseback Obligations
The Company enters into various finance lease and sales leaseback agreements. The terms of the lease agreements mature through November 2023, with monthly installment payments ranging from $1,455 to $40,173 and a fixed interest rate ranging from 3.75% to 12.73%.
The income tax expense was $442,943 for the three month period ended October 31, 2020 compared to an income tax expense of $316,106 for the same period in the prior fiscal year. The Company’s effective tax rate was 41.40% and 32.35% for the quarters ended October 31, 2020 and 2019, respectively. The income tax expense was $222,109 for the six month period ended October 31, 2020 compared to an income tax expense of $563,221 for the same period in the prior fiscal year. The Company’s effective tax rate was (429.63)% and 35.52% for the six month period ended October 31, 2020 and 2019, respectively. The increase in income tax expense and effective tax rate for the three month period ended October 31, 2020 compared to the same period in the previous year is due to an increase in income and variations in income earned by jurisdiction in the current period compared to the same period in the previous year. The decrease in income tax expense and effective tax rate for the six month period ended October 31, 2020 compared to the same period in the previous year is due to a decrease in income in the current six month period compared to the same period in the previous year. The negative effective tax rate in the current six month period is due to an overall pre-tax loss recognized in the current period but recognition of tax expense due to the mix of income by jurisdiction.
As described in Note E, the Company received a PPP Loan under the CARES Act of $6,282,963. For federal income tax purposes, the CARES Act expressly provides that any forgiveness or cancellation of all or part of such loans will not be treated as income for tax purposes. It is expected, however, that if the loan is deemed forgiven any deductions for the covered expenses that gave rise to the loan forgiveness will be disallowed to prevent a double tax benefit. As of October 31, 2020, the loan has not been forgiven and thus the expenses have not been disallowed for federal income tax purposes.
16
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note F - Income Tax - Continued
On November 18, 2020 the IRS issued Revenue Ruling 2020-27 which holds that a taxpayer’s covered expenses are not deductible if the taxpayer reasonably expects the loan to be forgiven. If the Company’s eligible expenses are deemed nondeductible prior to loan forgiveness, it is expected that the Company’s current tax liability will increase and that a deferred tax asset will be established related to those expenses. The Company has not changed its plans to indefinitely reinvest the earnings of the Company’s foreign subsidiaries. The cumulative amount of unremitted earnings for which U.S. income taxes have not been recorded is $4,681,000 as of October 31, 2020.
Note G - Commitments and Contingencies
From time to time the Company is involved in legal proceedings, claims or investigations that are incidental to the conduct of the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect that these legal proceedings or claims will have any material adverse impact on its future consolidated financial position, results of operations or cash flows.
Note H - Critical Accounting Policies
Management Estimates and Uncertainties - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for doubtful accounts, reserves for inventory, lower of cost or net realizable value for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of long-lived assets. Actual results could materially differ from these estimates.
The potential impact of future disruptions and continued economic uncertainty over COVID-19 may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders. It is reasonably possible that these potential adverse impacts may result in the recognition of material impairments of the Company’s long-lived assets or other related charges in future periods.
17
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note H - Critical Accounting Policies - Continued
Revenue Recognition - The following table presents the Company’s revenue disaggregated by the principal end-user markets it serves:
|
Three Months Ended |
Six Months Ended |
|||||||||||
|
October 31, |
October 31, |
|||||||||||
|
Net trade sales by |
2020 |
2019 |
2020 |
2019 |
||||||||
|
Industrial Electronics |
$ |
35,654,079 |
$ |
41,398,201 |
$ |
72,271,337 |
$ |
84,246,913 | ||||
|
Consumer Electronics |
30,671,077 | 28,815,556 | 51,839,316 | 55,474,743 | ||||||||
|
Medical / Life Sciences |
3,293,268 | 4,641,555 | 6,032,727 | 9,143,637 | ||||||||
|
Total Net Trade Sales |
$ |
69,618,424 |
$ |
74,855,312 |
$ |
130,143,380 |
$ |
148,865,293 | ||||
|
During the three and six month periods ending October 31, 2020, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods and no amounts were allocated to performance obligations that remain unsatisfied or partially unsatisfied at October 31, 2020. The Company is electing not to disclose the value of the remaining unsatisfied performance obligation with a duration of one year or less as permitted by the practical expedient in ASU 2014-09, “Revenue from Contracts with Customers.” The Company had no material remaining unsatisfied performance obligations as of October 31, 2020, with an expected duration of greater than one year.
Income Tax - The Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment.
Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized. The Company’s valuation allowance was $645,538 and $ 989,194 as of October 31, 2020 and April 30, 2020, respectively.
Investment in Wagz - As more fully described in Note I - Related Parties, the Company has recorded an investment in Wagz Inc. (“Wagz”), a privately held company whose equity does not have a readily
18
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note H - Critical Accounting Policies - Continued
determinable fair value. As permitted by ASC 321, Investments - Equity Securities, paragraph 321-35-2, the Company has elected to carry its investment in Wagz equity at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or a similar investment of the same issuer until the investment no longer qualifies to be measured under paragraph 321-35-2. At October 31, 2020 and April 30, 2020, the Company continued to recognize the fair value of the Wagz common stock at $600,000.
On May 29, 2020, Wagz entered into a Convertible Secured Promissory Note with the Company in the principal sum of up to $4,052,478. The outstanding principal amount of the Note is due and payable on the earliest to occur of (1) August 31, 2021; (2) upon the closing of a sale of all or substantially all of the assets or common stock of Wagz; or (3) an event of default (the Maturity Date). Interest is payable at the rate of four percent (4%) per annum and is payable on the Maturity Date. The Note is collateralized against substantially all assets of Wagz. At October 31, 2020, $3,778,179 was outstanding under other receivables compared to $768,500 at April 30, 2020.
On June 4, 2020, the Company and Wagz announced that they had executed a letter of intent (“LOI”) relating to a proposed business combination. Subject to the terms and conditions set forth in the LOI, the Company expects to issue approximately 2,270,000 shares of its common stock that would result in the stockholders of Wagz owning in the aggregate approximately one-third of the combined company. The parties expect the transaction to close by the end of the third quarter of fiscal year 2021 and the acquisition remains subject to achievement of certain milestones and satisfaction of conditions by both parties prior to closing such as finalizing a material definitive agreement, the Company raising additional capital that it projects will be needed for the expanded operations, and the approval by the stockholders of both the Company and Wagz.
New Accounting Standards:
In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13, as amended by ASU 2019-04 and ASU 2019-05, introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For small reporting companies, ASU 2016-13 is effective for annual and interim reporting periods beginning after December 15, 2022, and the guidance is to be applied using the modified-retrospective approach. Earlier adoption is permitted for annual and interim reporting periods beginning after December 15, 2018. The Company is currently evaluating the new guidance and has not determined the impact this ASU may have on its consolidated financial statements.
In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”, which simplifies accounting for income taxes by removing certain exceptions to intra-period allocations, investments, calculations in interim periods and to improve consistent application. ASU 2019-12 is effective for annual and interim reporting periods beginning
19
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note H - Critical Accounting Policies – Continued
after December 15, 2020. The Company is currently evaluating the new guidance and has not determined the impact this ASU may have on its consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional guidance for a period of time to ease the potential burden in accounting for the transition from reference rates that are expected to be discontinued. Regulators and market participants in various jurisdictions have undertaken efforts to eliminate certain reference rates and introduce new reference rates that are based on a larger and more liquid population of observable transactions. The changes provide optional expedients and exceptions for applying US GAAP to contract, hedging relationships and other transactions affected by reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 and can be adopted no later than December 31, 2022. The Company is currently evaluating the new guidance and has not determined the impact this ASU may have on its consolidated financial statements.
Note I - Related Parties
In March 2015, two of the Company’s executive officers invested in a start-up customer, Petzila, Inc. (“Petzila”). The executive officers’ investments constituted less than 2% (individually and in aggregate) of the outstanding beneficial ownership of Petzila, according to information provided by Petzila to the executive officers.
On April 30, 2018, the Company foreclosed on its security interest and held a public sale of the assets in accordance with the requirements of Article 9 of the California Uniform Commercial Code. The Company acquired all of the assets of Petzila as the winning bidder at the public sale by a credit bid of $3,500,000, the aggregate amount of Petzila’s liability to the company. Concurrent with the foreclosure sale, the Company entered into an Asset Purchase Agreement with Wagz whereby the Company sold the assets to Wagz for $350,000 cash, 600,000 shares of Wagz common stock and an earn-out based on sales by Wagz generated from use of the assets through July 31, 2022. The earn-out is $6.00 per unit of a product specified in the asset purchase agreement and any upgrade to such product.
The fair value of the non-cash consideration consisted of $600,000 for the 600,000 shares of Wagz common stock which is recorded within other assets. The Company determined the fair value of the equity using the price per common share received by Wagz in the most recent financing transaction, a level 3 input. The Company did not assign any value to the earn-out because any receipts from the earn-out are highly uncertain and contingent upon Wagz selling the product specified in the asset purchase agreement between the Company and Wagz. Accordingly, the Company recognized the fair value of the assets received from Wagz and derecognized the receivables from Petzila.
In November 2020, Wagz sought short-term financing for its operations and secured a commitment from Angel Business Credit, LLC (“ABC”) for a loan of $250,000 conditioned on Wagz granting ABC a security interest in its assets and Gary R. Fairhead executing a personal guaranty. Mr. Fairhead is the Company’s President and CEO; his personal guaranty requires the approval of the Audit Committee of the Company’s Board of Directors. After consideration, the Audit Committee determined that
20
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note I - Related Parties – Continued
Mr. Fairhead’s guaranty was in the best interests of the Company and approved the guaranty. The loan closed on November 12, 2020, and its principal, plus interest equal to $5,000, are due on the maturity date, December 10, 2020. The loan was paid in full on December 8, 2020. As a result, Mr. Fairhead’s guaranty was cancelled and ABC’s security interest was terminated.
Note J – Leases
The Company leases office and storage space, vehicles and other equipment under non-cancellable operating leases with initial terms typically ranging from 1 to 5 years. At contract inception, the Company reviews the facts and circumstances of the arrangement to determine if the contract is or contains a lease. The Company follows the guidance in Topic 842 to evaluate whether the contract has an identified asset; if the Company has the right to obtain substantially all economic benefits from the asset; and if the Company has the right to direct the use of the underlying asset. When determining if a contract has an identified asset, the Company considers both explicit and implicit assets, and whether the supplier has the right to substitute the asset. When determining if the Company has the right to direct the use of an underlying asset, the Company considers if they have the right to direct how and for what purpose the asset is used throughout the period of use and if they control the decision-making rights over the asset.
The Company’s lease terms may include options to extend or terminate the lease. The Company exercises judgment to determine the term of those leases when extension or termination options are present and include such options in the calculation of the lease term when it is reasonably certain that it will exercise those options.
The Company has elected to include both lease and non-lease components in the determination of lease payments. Payments made to a lessor for items such as taxes, insurance, common area maintenance, or other costs commonly referred to as executory costs, are also included in lease payments if they are fixed. The fixed portion of these payments are included in the calculation of the lease liability, while any variable portion would be recognized as variable lease expenses, when incurred. Variable payments made to third parties for these, or similar costs, such as utilities, are not included in the calculation of lease payments.
At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company exercises judgment in determining the incremental borrowing rate based on the information available at when the lease commences to measure the present value of future payments.
Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost includes amortization, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method.
Operating leases are included in other assets, current operating lease obligations, and operating lease obligations (less current portion) on the Company’s consolidated balance sheet. Finance leases are included in property, plant and equipment and current and long-term portion of finance lease
21
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note J – Leases – Continued
obligations on the Company’s consolidated balance sheet. Short term leases with an initial term of 12 months or less are not presented on the balance sheet with expense recognized as incurred.
The following table presents lease assets and liabilities and their balance sheet classification:
|
October 31, |
April 30, |
|||||
|
Classification |
2020 |
2020 |
||||
Operating Leases: |
|||||||
Right-of-use Assets |
Other assets |
$ |
7,333,290 |
$ |
7,235,166 | ||
Operating lease current |
Current portion of operating lease |
2,078,990 | 2,150,161 | ||||
Operating lease noncurrent |
Operating lease obligations, less |
5,457,117 | 5,281,811 | ||||
Finance Leases: |
|||||||
Right-of-use Assets |
Property, plant and equipment |
5,702,281 | 6,443,954 | ||||
Finance lease current |
Current portion of finance lease |
1,650,763 | 1,902,295 | ||||
Finance lease noncurrent |
Finance lease obligations, less |
1,124,309 | 1,884,722 |
The components of lease expense for the three and six month periods ended October 31, 2020 and 2019, are as follows:
|
Three Months |
Three Months |
Six Months |
Six Months |
|||||
|
Ended |
Ended |
Ended |
Ended |
|||||
|
October 31, |
October 31, |
October 31, |
October 31, |
|||||
|
Classification |
2020 |
2019 |
2020 |
2019 |
||||
Operating Leases: |
|||||||||
Operating lease cost |
Operating expenses |
353,317 | 625,339 | 727,012 | 1,219,833 | ||||
Variable lease cost |
Operating expenses |
78,347 | 73,897 | 156,694 | 147,794 | ||||
Short term lease cost |
Operating expenses |
1,350 | 1,350 | 2,700 | 2,700 | ||||
Finance Leases: |
|||||||||
Amortization of |
Operating expenses |
493,042 | 384,192 | 912,735 | 731,567 | ||||
Interest expense |
Interest expense |
56,043 | 74,340 | 122,401 | 142,126 | ||||
Total |
982,099 | 1,159,118 | 1,921,542 | 2,244,020 |
22
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note J – Leases – Continued
The weighted average lease term and discount rates for the quarter ended October 31, 2020 and 2019, are as follows:
|
October 31, |
October 31, |
||
|
2020 |
2019 |
||
Operating Leases: |
||||
Weighted average remaining lease term (months) |
58.40 |
44.20 |
||
Weighted average discount rate |
3.1% |
3.9% |
||
Finance Leases: |
||||
Weighted average remaining lease term (months) |
22.25 |
29.02 |
||
Weighted average discount rate |
7.7% |
6.5% |
Future payments due under leases reconciled to lease liabilities are as follows:
|
Operating Leases |
Finance Leases |
||||
For the remaining 6 months of the fiscal year ending April 30: |
||||||
2021 |
$ |
1,226,071 |
$ |
983,279 | ||
For the fiscal years ending April 30: |
||||||
2022 | 1,638,910 | 1,374,628 | ||||
2023 | 1,925,251 | 498,307 | ||||
2024 | 1,822,917 | 167,721 | ||||
2025 | 635,387 |
- |
||||
2026 | 146,489 |
- |
||||
Thereafter |
199,353 |
- |
||||
Total undiscounted lease payments |
7,594,378 | 3,023,935 | ||||
Present value discount, less interest |
58,271 | 248,863 | ||||
Lease liability |
$ |
7,536,107 |
$ |
2,775,072 |
23
SigmaTron International, Inc.
October 31, 2020
Notes to Condensed Consolidated Financial Statements
(Unaudited)
Note J – Leases – Continued
Supplemental disclosures of cash flow information related to leases for the six months ended October 31, 2020 and 2019 are as follows:
|
Six Months |
Six Months |
|
Ended |
Ended |
|
October 31, |
October 31, |
Other Information |
2020 |
2019 |
Cash paid for amounts included in the measurement of lease liabilities |
||
Operating cash flows from finance leases |
122,401 | 142,126 |
Operating cash flows from operating leases |
109,917 | 126,363 |
Financing cash flows from finance leases |
1,011,945 | 1,162,403 |
Supplemental non-cash information on lease labilities arising from |
||
Right-of-use assets obtained in exchange for |
- |
671,446 |
Right-of-use assets obtained in exchange for |
1,162,451 | 1,630,006 |
24
SigmaTron International, Inc.
October 31, 2020
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.
In addition to historical financial information, this discussion of the business of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries Standard Components de Mexico S.A., AbleMex, S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and SigmaTron Electronic Technology Co., Ltd. (collectively, “SigmaTron China”) and international procurement office SigmaTron Taiwan branch (collectively, the “Company”) and other Items in this Quarterly Report on Form 10-Q contain forward-looking statements concerning the Company’s business or results of operations. Words such as “continue,” “anticipate,” “will,” “expect,” “believe,” “plan,” and similar expressions identify forward-looking statements. These forward-looking statements are based on the current expectations of the Company. Because these forward-looking statements involve risks and uncertainties, the Company’s plans, actions and actual results could differ materially. Such statements should be evaluated in the context of the direct and indirect risks and uncertainties inherent in the Company’s business including, but not necessarily limited to, the risks inherent in any merger and business combination, the Company’s continued dependence on certain significant customers; the continued market acceptance of products and services offered by the Company and its customers; pricing pressures from the Company’s customers, suppliers and the market; the activities of competitors, some of which may have greater financial or other resources than the Company; the variability of the Company’s operating results; the results of long-lived assets impairment testing; the ability to achieve the expected benefits of acquisitions; the collection of aged account receivables; the variability of the Company’s customers’ requirements; the availability and cost of necessary components and materials; the ability of the Company and its customers to keep current with technological changes within its industries; regulatory compliance, including conflict minerals; the continued availability and sufficiency of the Company’s credit arrangements, including the phase-out of LIBOR; the ability to meet the Company’s financial covenant; changes in U.S., Mexican, Chinese, Vietnamese or Taiwanese regulations affecting the Company’s business; the turmoil in the global economy and financial markets; the spread of COVID-19 (commonly known as “Coronavirus”) which has threatened the Company’s financial stability by causing a decrease in consumer revenues, caused a disruption to the Company’s global supply chain, caused plant closings or reduced operations thus reducing output at those facilities; the stability of the U.S., Mexican, Chinese, Vietnamese and Taiwanese economic, labor and political systems and conditions; currency exchange fluctuations; and the ability of the Company to manage its growth. These and other factors which may affect the Company’s future business and results of operations are identified throughout the Company’s Annual Report on Form 10-K, and as risk factors, may be detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These statements speak as of the date of such filings, and the Company undertakes no obligation to update such statements in light of future events or otherwise unless otherwise required by law.
25
SigmaTron International, Inc.
October 31, 2020
Overview:
The Company operates in one business segment as an independent provider of EMS, which includes printed circuit board assemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the Company also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; and (6) assistance in obtaining product approval from governmental and other regulatory bodies. The Company provides these manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan.
The Company relies on numerous third-party suppliers for components used in the Company’s production process. Certain of these components are available only from single-sources or a limited number of suppliers. In addition, a customer’s specifications may require the Company to obtain components from a single-source or a small number of suppliers. The loss of any such suppliers could have a material impact on the Company’s results of operations. Further, the Company could operate at a cost disadvantage compared to competitors who have greater direct buying power from suppliers. The Company does not enter into long-term purchase agreements with major or single-source suppliers. The Company believes that short-term purchase orders with its suppliers provides flexibility, given that the Company’s orders are based on the changing needs of its customers.
Sales levels can vary considerably among customers and products depending on the type of services (turnkey versus consignment) rendered by the Company and the demand by customers. Consignment orders require the Company to perform manufacturing services on components and other materials supplied by a customer, and the Company charges only for its labor, overhead and manufacturing costs, plus a profit. In the case of turnkey orders, the Company provides, in addition to manufacturing services, the components and other materials used in assembly. Turnkey contracts, in general, have a higher dollar volume of sales for each given assembly, owing to inclusion of the cost of components and other materials in net sales and cost of goods sold. Variations in the number of turnkey orders compared to consignment orders can lead to significant fluctuations in the Company’s revenue and gross margin levels. Consignment orders accounted for less than 1% of the Company’s revenues for the three and six month periods ended October 31, 2020 and 2019, respectively.
The Company’s international footprint provides our customers with flexibility within the Company to manufacture in China, Mexico, Vietnam or the U.S. We believe this strategy will continue to serve the Company well as its customers continuously evaluate their supply chain strategies.
The Company’s recovery continued from the downturn experienced in April and May of this year and the Company had a solid second quarter for this fiscal year. In the fiscal quarter ended October 31, 2020 the Company recorded pre-tax profit of $1,069,801 on revenue of $69,618,424. While the revenue was down, the mix was favorable for the quarter. In addition, these results were achieved after expenses directly related to COVID-19 of $661,000 for the first six months of this fiscal year. These expenditures include wages paid to employees in Mexico who are required to be paid, but are not working based on government regulations in Mexico, COVID supply expenses and infrastructure expenses for social distancing. COVID-19 related expenses will continue in all likelihood for the balance of this fiscal year.
At this time, the backlog continues to be strong for our third quarter of fiscal 2021. Some of the Company’s customers have unexpectedly benefited from the pandemic and having people spend more
26
SigmaTron International, Inc.
October 31, 2020
time at home, while others continue to be depressed in terms of demand. In addition, several of the Company’s customers apparently took their inventory lower than demand and they are now expediting orders for delivery as soon as possible. How long this will last is hard to determine. If indeed, the economy continues to grow as it has recently, the Company believes it is well positioned for the second half of fiscal 2021. The Company has recently landed several new opportunities that bode well for fiscal 2022. However, as positive as things are now, the situation remains fluid and volatile and could change for our customers quickly. The unexpected increase in demand created challenges on the supply side regarding components and lead-times.
As previously reported, the Company received a PPP Loan in April 2020 and it recorded it as a liability on its balance sheet. The Company has not yet applied for forgiveness. Also, as previously reported, the Company and Wagz continue to work towards a deal under which the Company will acquire Wagz. The Company is hopeful that the transaction will be closed by the end of the third fiscal quarter.
In summary, the second quarter was a good one and the Company continues to head in the right direction. Many of the short-term challenges now are the ones tied to un-forecasted demand inside of lead-time. The Company’s customers seem to be more optimistic because of the vaccine, which is also encouraging. Finally, the Company believes that the opportunities with Wagz continue to grow and the combination of the two companies will ultimately benefit all shareholders involved.
Results of Operations:
The following table sets forth selective financial data as a percentage of net sales for the periods indicated.
|
Three Months |
Three Months |
Six Months |
Six Months |
|||
|
Ended |
Ended |
Ended |
Ended |
|||
|
October 31, |
October 31, |
October 31, |
October 31, |
|||
|
2020 |
2019 |
2020 |
2019 |
|||
|
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) |
|||
|
|||||||
Net sales |
100.0% |
100.0% |
100.0% |
100.0% |
|||
Operating expenses: |
|||||||
Cost of products sold |
90.3 |
90.5 |
91.5 |
90.5 |
|||
Selling and administrative expenses |
7.8 |
7.6 |
8.1 |
7.7 |
|||
Total operating expenses |
98.1 |
98.1 |
99.6 |
98.2 |
|||
Operating income |
1.9% |
1.9% |
0.4% |
1.8% |
Net Sales
Net sales decreased for the three month period ended October 31, 2020, to $69,618,424 from $74,855,312 for the three month period ended October 31, 2019. Net sales decreased for the six month period ended October 31, 2020 to $130,143,380 from $148,865,293 for the six month period ended October 31, 2019. The Company’s sales decreased for the three month period ended October 31, 2020, as compared to the prior year in the industrial electronics and medical/life science marketplaces. The decrease in sales dollars for these marketplaces was partially offset by an increase in sales dollars in the consumer electronics marketplace. The Company’s sales decreased for the six month period
27
SigmaTron International, Inc.
October 31, 2020
ended October 31, 2020, as compared to the prior year in the industrial electronics and medical/life science marketplaces. The decrease in sales dollars for these marketplaces was partially offset by an increase in sales dollars in the consumer electronics marketplace. Sales decreased by approximately 10% for the three and six month periods ended October 31, 2020, as compared to the same periods in the prior year due to the COVID-19 pandemic. As of October 31, 2020, the customer backlog remains strong for the third fiscal quarter. The COVID-19 situation remains volatile and customer demand could change quickly.
Gross Profit
Gross profit dollars decreased during the three month period ended October 31, 2020, to $6,759,542 or 9.7% of net sales compared to $7,129,486 or 9.5% of net sales for the same period in the prior fiscal year. Gross profit dollars decreased during the six month period ended October 31, 2020, to $11,031,733 or 8.5% of net sales compared to $14,089,818 or 9.5% of net sales for the same period in the prior fiscal year. The decrease in gross profit for the three and six month periods ended October 31, 2020, was primarily the result of decreased sales due to the COVID-19 pandemic and approximately $661,000 of COVID-19 related expenses. It is likely the COVID-19 related expenses will continue for the balance of this fiscal year.
Selling and Administrative Expenses
Selling and administrative expenses decreased to $5,421,739 or 7.8% of net sales for the three month period ended October 31, 2020, compared to $5,700,288 or 7.6% of net sales for the same period in the prior fiscal year. The net decrease in selling and administrative expenses for the three month period ended October 31, 2020, was attributable to a decrease in sales salaries, financing fees and accounting professional fees. The decrease in the foregoing selling and administrative expenses was partially offset by an increase in general insurance and legal professional fees. Selling and administrative expenses decreased to $10,481,264 or 8.1% of net sales for the six month period ended October 31, 2020, compared to $11,527,614 or 7.7% of net sales for the same period in the prior fiscal year. The net decrease in selling and administrative expenses for the six month period ended October 31, 2020, was attributable to a decrease in sales salaries, financing fees and bonus expense. The decrease in the foregoing selling and administrative expenses was partially offset by an increase in general insurance and legal professional fees.
Interest Expense
Interest expense decreased to $308,613 for the three month period ended October 31, 2020, compared to $462,772 for the same period in the prior fiscal year. Interest expense decreased to $646,877 for the six month period ended October 31, 2020, compared to $1,054,000 for the same period in the prior fiscal year. The decrease in interest expense for the three and six month periods ended October 31, 2020, was due to the decreased borrowings under the Company’s banking arrangements and mortgage obligations.
The income tax expense was $442,943 for the three month period ended October 31, 2020, compared to an income tax expense of $316,106 for the same period in the prior fiscal year. The Company’s effective tax rate was 41.40% and 32.35% for the quarters ended October 31, 2020 and 2019, respectively. The income tax expense was $222,109 for the six month period ended October 31, 2020, compared to an income tax expense of $563,221 for the same period in the prior fiscal year. The
28
SigmaTron International, Inc.
October 31, 2020
Company’s effective tax rate was (429.63)% and 35.52% for the six month period ended October 31, 2020 and 2019, respectively. The increase in income tax expense and effective tax rate for the three month period ended October 31, 2020 compared to the same period in the previous year is due to an increase in income and variations in income earned by jurisdiction in the current period compared to the same period in the previous year. The decrease in income tax expense and effective tax rate for the six month period ended October 31, 2020 compared to the same period in the previous year is due to a decrease in income in the current six month period compared to the same period in the previous year. The negative effective tax rate in the current six month period is due to an overall pre-tax loss recognized in the current period but recognition of tax expense due to the mix of income by jurisdiction.
Net Income
Net income decreased to $626,858 for the three month period ended October 31, 2020, compared to net income of $661,183 for the same period in the prior fiscal year. Net income decreased to a net loss of $273,808 for the six month period ended October 31, 2020, compared to net income of $1,022,208 for the same period in the prior fiscal year. Basic and diluted earnings per share for the second quarter of fiscal year 2021 were $0.15, compared to basic and diluted earnings per share of $0.16 and $0.15, respectively, for the same period in the prior fiscal year. Basic and diluted loss per share for the six month period ended were ($0.06), compared to basic and diluted earnings per share of $0.24 for the same period in the prior fiscal year.
Liquidity and Capital Resources:
Operating Activities.
Cash flow provided by operating activities was $3,531,711 for the six months ended October 31, 2020. During the first six months of fiscal year 2021, cash flow provided by operating activities was primarily the result of a decrease in accounts receivable and inventory of $6,171,838 and $3,239,189, respectively. Cash flow provided by operating activities was partially offset by the result of a decrease in accounts payable of $11,288,257. The decrease in accounts payable was primarily the result of the timing of payments.
Cash flow provided by operating activities was $11,392,857 for the six months ended October 31, 2019. During the first six months of fiscal year 2020, cash flow provided by operating activities was primarily the result of net income, a decrease in inventory of $14,164,330, a decrease in accounts receivable of $1,516,504 and an increase in accrued expenses and wages. The decrease in inventory was primarily the result of increased sales and the implementation of an inventory reduction program. Cash flow provided by operating activities was partially offset by the result of a decrease in accounts payable of $10,673,778.
Investing Activities.
For the six months ended October 31, 2020, the Company purchased $2,470,920 in machinery and equipment to be used in the ordinary course of business. The Company has received forecasts from current customers for increased business that would require additional investment in capital equipment and facilities. To the extent that these forecasts come to fruition, the Company anticipates that it will make additional machinery and equipment purchases in fiscal year 2021. The Company anticipates future purchases will be funded by lease transactions. During the first six months of fiscal year 2020,
29
SigmaTron International, Inc.
October 31, 2020
the Company purchased $588,334 in machinery and equipment used in the ordinary course of business. The Company made additional machinery and equipment purchases of $3,386,545 during the balance of fiscal year 2020.
Financing Activities.
Cash used in financing activities of $271,898 for the six months ended October 31, 2020, was primarily the result of net payments under the line of credit.
Cash used in financing activities of $8,339,867 for the six months ended October 31, 2019, was primarily the result of net payments under the line of credit.
Financing Summary.
Notes Payable – Banks
On March 31, 2017, the Company entered into a $35,000,000 senior secured credit facility with U.S. Bank, which expires on March 31, 2022. The credit facility is collateralized by substantially all of the Company’s domestically located assets. The facility allows the Company to choose among interest rates at which it may borrow funds: the bank fixed rate of five percent or LIBOR plus one and one half percent (effectively 1.75% at October 31, 2020). Interest is due monthly.
On July 16, 2018, the Company and U.S. Bank entered into an amendment of the revolving line of credit under the senior secured credit facility. The amended revolving credit facility allows the Company to borrow up to the lesser of (i) $45,000,000 (the “Revolving Line Cap”) less reserves or (ii) the Borrowing Base, but no more than 90% of the Company’s Revolving Line Cap, except that the 90% limitation will expire if (i) the Company’s actual revolving loans for 90 consecutive days after the amendment’s effective date are less than 80% of the Company’s Borrowing Base and (ii) the Company maintains a Fixed Charge Coverage Ratio of 1.2 to 1.0 for four consecutive quarters. The amendment also imposes sublimits on categories of inventory of $10,500,000 on raw materials, $10,000,000 on finished goods and $28,000,000 on all eligible inventory.
On December 13, 2018, the Company and U.S. Bank entered into an amendment of the revolving credit facility. The amendment provides an exception to otherwise ineligible foreign receivables for up to $3,000,000 of receivables paid by certain enumerated account debtors outside of the U.S. and Canada.
On July 15, 2020 and August 7, 2020, the Company and U.S. Bank entered into amendments of the revolving credit facility. The amendments revised the Fixed Charge Coverage Ratio.
On September 8, 2020, the Company and U.S. Bank entered into an amendment of the revolving credit facility. The amendment allows the Company to borrow up to the lesser of (i) the Revolving Line Cap less reserves or (ii) the Borrowing Base, but no more than 80% of the Company’s Revolving Line Cap. The amendment also imposes sublimits on categories of other investments to $4,000,000.
As of October 31, 2020, there was $25,500,000 outstanding and $4,286,052 of unused availability under the U.S. Bank facility compared to an outstanding balance of $26,884,494 and $13,850,575 of unused availability at April 30, 2020. Deferred financing costs of $13,369 and $21,424 were capitalized during the three and six month periods ended October 31, 2020, respectively, which are
30
SigmaTron International, Inc.
October 31, 2020
amortized over the term of the agreement. As of October 31, 2020 and April 30, 2020, the unamortized amount offset against outstanding debt was $179,328 and $218,062, respectively.
On April 23, 2020, the Company received a PPP Loan from U.S. Bank, as lender, pursuant to the CARES Act, as administered by the SBA in the amount of $6,282,973. The PPP Loan, in the form of a promissory note, matures on April 23, 2022. No additional collateral or guarantees were provided by the Company for the PPP Loan. The PPP Loan provides for customary events of default. Under the CARES Act, loan forgiveness may be available for the sum of documented payroll costs, rent payments, mortgage interest and covered utilities during the 24-week period beginning on the date of loan disbursement. The amount of loan forgiveness will be reduced if recipients terminate employees or reduce salaries during the covered period. The Company may be required to repay any portion of the outstanding principal that is not forgiven, along with accrued interest, and it cannot provide any assurance that it will be eligible for loan forgiveness, or that any amount of the PPP Loan will ultimately be forgiven by the SBA. All aspects of the PPP Loan are subject to review by the SBA, including without limitation, the Company’s eligibility for and the size of the loan. The review procedures have not been made public. The Company cannot predict the outcome of that review nor be assured that all or any part of the PPP Loan will be forgiven. To the extent that all or part of the PPP Loan is not forgiven, the Company will be required to make payments, including interest accruing at an annual interest rate of 1.0%, beginning on the date of disbursement.
On March 15, 2019, the Company’s wholly-owned subsidiary, SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. Under the agreement SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $1,490,000 as of October 31, 2020, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 6.09%. The term of the facility extends to March 14, 2024. There was $498,275 outstanding under the facility at October 31, 2020 compared to an outstanding balance of $304,658 at April 30, 2020.
Notes Payable – Buildings
The Company entered into a mortgage agreement on December 21, 2017, in the amount of $5,200,000, with U.S. Bank to refinance the property that serves as the Company’s corporate headquarters and its Illinois manufacturing facility in Elk Grove Village, Illinois. The note requires the Company to pay monthly principal payments in the amount of $17,333, bears interest at a fixed rate of 4.0% per year and is payable over a fifty-one month period. Deferred financing costs of $74,066 were capitalized in fiscal year 2018 which are amortized over the term of the agreement. As of October 31, 2020, the unamortized amount included as a reduction to long-term debt was $24,214. A final payment of approximately $4,347,778 is due on or before March 31, 2022. The outstanding balance was $4,628,000 and $4,732,000 at October, 31 2020 and April 30, 2020, respectively.
The Company entered into a mortgage agreement on December 21, 2017, in the amount of $1,800,000, with U.S. Bank to refinance the property that serves as the Company’s engineering and design center in Elgin, Illinois. The note requires the Company to pay monthly principal payments in the amount of $6,000, bears interest at a fixed rate of 4.0% per year and is payable over a fifty-one month period. Deferred financing costs of $65,381 were capitalized in the fiscal year 2018 which are amortized over the term of the agreement. As of October 31, 2020 the unamortized amount included as a reduction to long-term debt was $21,374. A final payment of approximately $1,505,000 is due on or before March 31, 2022. The outstanding balance was $1,602,000 and $1,638,000 at October, 31 2020 and April 30, 2020, respectively.
31
SigmaTron International, Inc.
October 31, 2020
The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank and Trust SSB to purchase the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103, bears interest at a fixed rate of 5.75% per year and is payable over a 120 month period. The outstanding balance was $531,578 and $552,561 at October 31, 2020 and April, 30 2020, respectively.
Notes Payable – Equipment
The Company routinely enters into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of these secured note agreements mature from November 2021 through May 2023, with quarterly installment payments ranging from $11,045 to $37,941 and a fixed interest rate ranging from 6.65% to 8.00%.
The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of these secured note agreements mature from March 2025 through October 2025, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate of 8.25%.
Finance Lease and Sales Leaseback Obligations
The Company enters into various finance lease and sales leaseback agreements. The terms of the lease agreements mature through November 2023, with monthly installment payments ranging from $1,455 to $40,173 and a fixed interest rate ranging from 3.75% to 12.73%.
Other
The Company provides funds for salaries, wages, overhead and capital expenditure items as necessary to operate its wholly-owned Mexican, Vietnamese and Chinese subsidiaries and the Taiwan IPO. The Company provides funding in U.S. Dollars, which are exchanged for Pesos, Dong, Renminbi, and New Taiwan dollars. The fluctuation of currencies from time to time, without an equal or greater increase in inflation, could have a material impact on the financial results of the Company. The impact of currency fluctuations for the six month period ended October 31, 2020, resulted in net foreign currency transaction losses of $165,209 compared to net foreign currency losses of approximately $262,000 for the same period in the prior year. During the six months of fiscal year 2021, the Company paid approximately $27,750,000 to its foreign subsidiaries for manufacturing services. All intercompany balances have been eliminated upon consolidation.
The Company has not changed its plans to indefinitely reinvest the earnings of the Company’s foreign subsidiaries. The cumulative amount of unremitted earnings for which U.S. income taxes have not been recorded is $4,681,000 as of October 31, 2020.
The Company expects that the significant disruption in business activity and the financial markets created by the COVID-19 global pandemic will impact several sources of its liquidity, and is therefore continuously and critically reviewing its liquidity and anticipated capital requirements. For more information on the potential impact of the COVID-19 pandemic on the Company, see Note B - Basis of Presentation.
The impact of inflation on the Company’s net sales, revenues and income from operations for the past two fiscal years has been minimal.
32
SigmaTron International, Inc.
October 31, 2020
Off-balance Sheet Transactions:
The Company has no off-balance sheet transactions.
Tabular Disclosure of Contractual Obligations:
As a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.
Item 3.Quantitative and Qualitative Disclosures About Market Risks.
As a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.
Item 4.Controls and Procedures.
Disclosure Controls:
The Company’s management, including its President and Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rules 13a-15(e) and 15(d)-15(e) thereunder) as of October 31, 2020. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and its President and Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of October 31, 2020.
Internal Controls:
There has been no change in the Company’s internal control over financial reporting during the six months ended October 31, 2020, that has materially affected or is reasonably likely to materially affect, its internal control over financial reporting. The Company’s internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with U.S. GAAP.
From time to time the Company is involved in legal proceedings, claims, or investigations that are incidental to the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect these legal proceedings or claims will have any material adverse impact on its future consolidated financial position, results of operations or cash flows.
33
SigmaTron International, Inc.
October 31, 2020
Item 1A. Risk Factors.
As a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
None.
34
SigmaTron International, Inc.
October 31, 2020
|
|
10.1 |
|
|
|
10.2 |
|
|
|
10.3 |
|
|
|
10.4 |
|
|
|
31.1 |
|
|
|
31.2 |
|
|
|
32.1 |
|
|
|
32.2 |
|
|
|
101.INS |
XBRL Instance Document |
|
|
101.SCH |
XBRL Taxonomy Extension Scheme Document |
|
|
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document |
|
|
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document |
35
SigmaTron International, Inc.
October 31, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGMATRON INTERNATIONAL, INC.
/s/ Gary R. Fairhead |
December 11, 2020 |
|
|
||
Gary R. Fairhead |
Date |
|
President and CEO (Principal Executive Officer) |
||
|
||
|
||
/s/ Linda K. Frauendorfer |
December 11, 2020 |
|
Linda K. Frauendorfer |
Date |
|
Chief Financial Officer, Secretary and Treasurer |
||
(Principal Financial Officer and Principal |
||
Accounting Officer) |
36